Literature DB >> 1430091

Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans.

M J Mellman1, M R Davis, H Shamoon.   

Abstract

UNLABELLED: We evaluated the effect of continuous physiological hyperinsulinemia on counterregulatory hormone responses in seven healthy subjects, each studied on two occasions. Hormone responses were measured during identical 2-h periods of hypoglycemia (plasma glucose target 3.5 mmol/L) at insulin levels of 350 pmol/L or 640 pmol/L. During hypoglycemia, there were significant (50-1400%) increases in glucagon, epinephrine, norepinephrine, GH, and cortisol which were comparable in the two groups. We further evaluated the influence of the duration of mild hyperinsulinemia on the responses in an additional group of normal subjects (n = 7). Brief (30 min) exposure to insulin was compared to a prolonged (3.5 h) insulin infusion, each followed by identical hypoglycemia. Plasma insulin (approximately 350 pmol/L) and plasma glucose (target 3.3 mmol/L) were similar in both groups. The increases in epinephrine, norepinephrine, GH, and cortisol during hypoglycemia were virtually identical in the two groups. However, the secretion of glucagon was blunted following prolonged hyperinsulinemia, increasing to levels of 249 +/- 17 ng/L in the brief studies and to only 185 +/- 20 ng/L in the prolonged studies (P < 0.005). The insulin-induced decrement in plasma amino acids were similar in the two studies and could not account for the impaired glucagon secretory response.
CONCLUSIONS: 1) Brief exposure to even high physiological levels of insulin do not alter the magnitude of counterregulatory hormone secretion during hypoglycemia; 2) prolonged hyperinsulinemia results in a selective blunting of the plasma glucagon response to hypoglycemia, perhaps due to a direct suppressive effect of insulin on alpha-cell secretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430091     DOI: 10.1210/jcem.75.5.1430091

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.

Authors:  H Shamoon; S Friedman; C Canton; L Zacharowicz; M Hu; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

2.  Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.

Authors:  Sachin A Paranjape; Owen Chan; Wanling Zhu; Adam M Horblitt; Ewan C McNay; James A Cresswell; Jonathan S Bogan; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

3.  Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia.

Authors:  Kelly A Diggs-Andrews; Xuezhao Zhang; Zhentao Song; Dorit Daphna-Iken; Vanessa H Routh; Simon J Fisher
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

4.  Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation.

Authors:  Kent K Ishihara; Samuel C Haywood; Dorit Daphna-Iken; Erwin C Puente; Simon J Fisher
Journal:  Metabolism       Date:  2009-06       Impact factor: 8.694

5.  Evidence that the brain of the conscious dog is insulin sensitive.

Authors:  S N Davis; C Colburn; R Dobbins; S Nadeau; D Neal; P Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

6.  Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.

Authors:  Eric Lontchi-Yimagou; Sandra Aleksic; Raphael Hulkower; Rebekah Gospin; Akankasha Goyal; Bryan Kuo; William G Mitchell; Jee Young You; Laxmi Upadhyay; Michelle Carey; Oana A Sandu; Ilan Gabriely; Harry Shamoon; Meredith Hawkins
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

7.  A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans.

Authors:  Patrick E MacDonald; Yang Zhang De Marinis; Reshma Ramracheya; Albert Salehi; Xiaosong Ma; Paul R V Johnson; Roger Cox; Lena Eliasson; Patrik Rorsman
Journal:  PLoS Biol       Date:  2007-06       Impact factor: 8.029

8.  Activation of Protein Kinase A (PKA) signaling mitigates congenital hyperinsulinism associated hypoglycemia in the Sur1-/- mouse model.

Authors:  Mangala M Soundarapandian; Christine A Juliana; Jinghua Chai; Patrick A Haslett; Kevin Fitzgerald; Diva D De León
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

9.  Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature.

Authors:  Therese W Fabricius; Clementine E M Verhulst; Peter L Kristensen; Cees J Tack; Rory J McCrimmon; Simon Heller; Mark L Evans; Stephanie A Amiel; Thomas R Pieber; Bastiaan E de Galan; Ulrik Pedersen-Bjergaard
Journal:  Diabetologia       Date:  2021-02-10       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.